CHANCE - Candesartan in Hypertrophic Cardiomyopathy

This study is ongoing, but not recruiting participants.

Study NCT00430833 Information provided by Charles University, Czech Republic

First Received: January 31, 2007 No Changes Posted

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given

No publications provided by Charles University, Czech Republic

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Penicka M, Gregor P, Kerekes R, Marek D, Curila K, Krupicka J; Candesartan use in Hypertrophic And Non-obstructive Cardiomyopathy Estate (CHANCE) Study Investigators. The effects of candesartan on left ventricular hypertrophy and function in nonobstructive hypertrophic cardiomyopathy: a pilot, randomized study. J Mol Diagn. 2009 Jan;11(1):35-41. Epub 2008 Dec 12.